← IndicationsOpen filtered programs
Landscape
Vestibular Disorders
Vestibular Disorders has 7 tracked records across 3 named organizations, including 1 strong-evidence records and 1 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
7
Pipeline Records
strong evidence + caveats + candidates
1
Strong Evidence
6 checked records with caveats
1
Active Programs
currently active
1
Marketed / Approved
commercial or approved
3
Organizations
companies, sponsors, and institutions
Competitive Density
11/100
organization breadth + program volume
Pipeline Velocity
19/100
active and late-stage share
Evidence Coverage
14/100
share strong evidence
Completion Signal
43/100
late-stage, approved, or marketed
Attrition Rate
0/100
share discontinued
Concentration
71/100
top-organization share
Programs by Stage
Phase 41 · 14%
Marketed1 · 14%
Not applicable5 · 71%
Trial / Program Status
Active1 · 14%
Marketed1 · 14%
Completed4 · 57%
Unknown1 · 14%
Modality Breakdown
Balance/Posturography Assessment1 · 14%
Clinical Assessment/Endpoint1 · 14%
Diagnostic1 · 14%
Genetic/Biomarker Study1 · 14%
Small Molecule1 · 14%
Small Molecule/Acupoint Injection1 · 14%
Steroid/Anti-inflammatory1 · 14%
Program Types
Diagnostic4 · 57%
Therapeutic3 · 43%
Top Organizations
Institution-led study5 · 71%
Institution-led study cluster1 · 14%
PATH MEDICAL1 · 14%
Population Tags
adult7 · 100%
age-related2 · 29%
pediatric2 · 29%
biomarker1 · 14%
clinical-audiology1 · 14%
congenital1 · 14%
healthy-volunteer1 · 14%
hearing-aid1 · 14%
meniere-disease1 · 14%
menieres-disease1 · 14%
Strong-Evidence Programs
1 recordsChecked Records With Caveats
6 recordsAudiovestibular biomarker DNA biobanking studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Genetic/Biomarker StudyNot applicableCompleted88% confidence
Hebei gastrodin acupoint injection SNHL vertigo studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Small Molecule/Acupoint InjectionNot applicableCompleted88% confidence
Meniere's disease ear-fullness assessment studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Clinical Assessment/EndpointNot applicableCompleted87% confidence
Posturography and hearing-aid fitting studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Balance/Posturography AssessmentNot applicableCompleted87% confidence
Oral versus intratympanic glucocorticoid ISSNHL vestibular prognosis studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Steroid/Anti-inflammatoryNot applicableUnknown84% confidence
Montelukast Hearing and Vestibular Study ClusterStatus caveat
Sponsor / Institution: Institution-led study cluster · Phase 4 · Active
Small MoleculePhase 4Active78% confidence